Literature DB >> 27270299

Stereotactic radiosurgery as a feasible treatment for intramedullary spinal arteriovenous malformations: a single-center observation.

Sherif Rashad1, Toshiki Endo2, Yoshihiro Ogawa3, Kenichi Sato4, Hidenori Endo1, Yasushi Matsumoto4, Akira Takahashi5, Teiji Tominaga1.   

Abstract

Spinal cord intramedullary arteriovenous malformations are rare. For patients suffering from either hemorrhage or myelopathy, surgical or endovascular interventions are indicated. However, complete eradication of the nidus is often difficult because of its intramedullary location and complex angioarchitecture. In this report, we evaluate the feasibility and safety of stereotactic radiosurgery as a treatment modality for intramedullary spinal arteriovenous malformations (AVMs). Between 2010 and 2014, we performed stereotactic radiosurgery to treat four patients with intramedullary AVM and one with spinal arteriovenous metameric syndrome (one woman and four men; age range, 31-66 years). Three patients presented with myelopathy, and two suffered hemorrhages. Nidi were located in the cervical (three cases) and thoracic (two cases) spinal cord regions. Based on the angioarchitecture, surgery and endovascular embolization were indicated. When both modalities were deemed hazardous, radiosurgery using CyberKnife™ was offered. Radiation using marginal doses of 18 Gy was administered in three fractions. The mean follow-up period was 37.2 months (range, 16-62 months). After treatment, two of the three patients with myelopathy experienced either improvement or stabilization of their symptoms and one experienced worsening of dysesthesia. In two patients with hemorrhage, symptoms improved in one and remained stable in the other. No further hemorrhagic episodes were evident during follow-up. Follow-up angiograms showed marked shrinkage of the nidus located in the thoracic spinal cord in one case and angiographic stabilization in the others. As a treatment modality for intramedullary AVMs, CyberKnife™ is safe and can be considered when surgery or endovascular therapy is not indicated. To determine optimum radiation doses and protocols for treating spinal AVMs, further studies with more patients and long-term follow-up are required.

Entities:  

Keywords:  Arteriovenous malformation; CyberKnife; Intramedullary; Myelopathy; Spinal cord

Mesh:

Year:  2016        PMID: 27270299     DOI: 10.1007/s10143-016-0758-z

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  23 in total

Review 1.  Radiation dose-volume effects in the spinal cord.

Authors:  John P Kirkpatrick; Albert J van der Kogel; Timothy E Schultheiss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  The prognosis of patients with spinal vascular malformations.

Authors:  M J Aminoff; V Logue
Journal:  Brain       Date:  1974-03       Impact factor: 13.501

3.  Microsurgical management of glomus spinal arteriovenous malformations: pial resection technique: Clinical article.

Authors:  Gregory J Velat; Steve W Chang; Adib A Abla; Felipe C Albuquerque; Cameron G McDougall; Robert F Spetzler
Journal:  J Neurosurg Spine       Date:  2012-04-06

4.  Cobb syndrome in an infant: treatment with endovascular embolization and corticosteroid therapy: case report.

Authors:  Akio Soeda; Nobuyuki Sakai; Koji Iihara; Izumi Nagata
Journal:  Neurosurgery       Date:  2003-03       Impact factor: 4.654

5.  Spinal glomus (type II) arteriovenous malformations: a pooled analysis of hemorrhage risk and results of intervention.

Authors:  Bradley A Gross; Rose Du
Journal:  Neurosurgery       Date:  2013-01       Impact factor: 4.654

6.  Treatment of spinal tumors using cyberknife fractionated stereotactic radiosurgery: pain and quality-of-life assessment after treatment in 200 patients.

Authors:  Gregory J Gagnon; Nadim M Nasr; Jay J Liao; Inge Molzahn; David Marsh; Donald McRae; Fraser C Henderson
Journal:  Neurosurgery       Date:  2009-02       Impact factor: 4.654

7.  CyberKnife radiosurgery for malignant spinal tumors: characterization of well-suited patients.

Authors:  Berndt Wowra; Stefan Zausinger; Christian Drexler; Markus Kufeld; Alexander Muacevic; Michael Staehler; Joerg-Christian Tonn
Journal:  Spine (Phila Pa 1976)       Date:  2008-12-15       Impact factor: 3.468

8.  Embolization of spinal intramedullary arteriovenous malformations using the liquid embolic agent, Onyx: a single-center experience in a series of 17 patients.

Authors:  Rufus A Corkill; Aristotelis P Mitsos; Andrew J Molyneux
Journal:  J Neurosurg Spine       Date:  2007-11

9.  Classification of spinal cord arteriovenous shunts: proposal for a reappraisal--the Bicêtre experience with 155 consecutive patients treated between 1981 and 1999.

Authors:  Georges Rodesch; Michel Hurth; Hortensia Alvarez; Marc Tadié; Pierre Lasjaunias
Journal:  Neurosurgery       Date:  2002-08       Impact factor: 4.654

10.  Spinal arteriovenous metameric syndrome: clinical manifestations and endovascular management.

Authors:  Y Niimi; N Uchiyama; L Elijovich; A Berenstein
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

View more
  2 in total

1.  Ruptured Spinal Arteriovenous Malformation: A Rare Cause of Paraplegia in Pregnancy.

Authors:  Clare E Thiele
Journal:  Case Rep Obstet Gynecol       Date:  2018-08-09

2.  Stereotactic Radiotherapy for Intramedullary Spinal Arteriovenous Malformations.

Authors:  Yoshimasa Mori; Chisa Hashizume; Takahiko Tsugawa; Sachiko Kato; Yuta Shibamoto
Journal:  Cureus       Date:  2018-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.